Fundz

Amani Therapeutics Appoints Rob Swoboda as Chief Operating Officer and Carla Canuso as Chief Medical Officer

PRIVATEMar 23, 2026

Position

Chief Medical Officer

Company

Amani Therapeutics

Carla Canuso, MD
BiotechnologyHealth CareTherapeutics

Description

Amani Therapeutics has announced the appointment of its executive leadership team following the closing of a $25 million Series A financing. Rob Swoboda joins as Chief Operating Officer and Carla Canuso, MD, takes on the role of Chief Medical Officer.

Quick answer

Amani Therapeutics Appoints Rob Swoboda as Chief Operating Officer and Carla Canuso as Chief Medical Officer (March 23, 2026).

What did Amani Therapeutics announce on March 23, 2026?
Amani Therapeutics has announced the appointment of its executive leadership team following the closing of a $25 million Series A financing. Rob Swoboda joins as Chief Operating Officer and Carla Canuso, MD, takes on the role of Chief Medical Officer.
What does Amani Therapeutics do?
Amani Therapeutics is a biotechnology company dedicated to developing highly efficacious, safer medicines for people living with serious neuropsychiatric disorders.
Which similar companies made leadership changes around the same time?
Aurinia Pharma (March 23, 2026), TuHURA Biosciences (March 23, 2026), Oryon Cell Therapies (March 23, 2026) and Vera Therapeutics, Inc. (March 25, 2026) also announced leadership changes within 45 days of Amani Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Amani Therapeutics, and when

A new leader at Amani Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Amani Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Amani Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Amani Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Amani Therapeutics

About

Amani Therapeutics is a biotechnology company dedicated to developing highly efficacious, safer medicines for people living with serious neuropsychiatric disorders. The company focuses on AM-01, a potential best-in-class therapy for schizophrenia, which combines clozapine with a novel chemical entity. Their goal is to improve treatment safety and efficacy for patients who are often underserved by existing therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Amani Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Amani Therapeutics's next move

Learn about Strategic plan

Amani Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.